|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,934.00 JPY | -1.02% |
|
-2.34% | -25.29% |
| 04-13 | Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8% | MT |
| 04-13 | Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.02% | -2.34% | -3.97% | -10.51% | -25.29% | -34.39% | -16.01% | -29.36% | +15.96% | 2.95B | |
| -0.03% | -5.15% | -7.29% | -15.71% | -31.48% | -13.62% | -9.54% | -28.55% | -21.68% | 5.54B | |
| -0.61% | +6.60% | +5.11% | -9.52% | -15.39% | -2.23% | +51.41% | +8.14% | +61.55% | 3.52B | |
| -2.08% | -3.33% | -0.08% | -5.23% | -13.77% | -15.82% | -14.21% | +3.86% | -22.40% | 2.75B | |
| +1.75% | -4.01% | -2.66% | -0.38% | -21.80% | +2.78% | +33.93% | +32.22% | - | 2.12B | |
| -0.68% | -2.98% | -4.71% | -14.18% | -20.68% | -45.01% | -49.71% | -62.30% | -40.58% | 1.33B | |
| -0.31% | -1.22% | -0.46% | +0.31% | -3.29% | +1.57% | -9.14% | +0.94% | +11.15% | 1.3B | |
| +0.57% | -0.28% | +14.38% | +17.02% | +16.67% | +26.49% | +59.96% | +59.74% | +35.55% | 482M | |
| -0.80% | -2.88% | +3.63% | -7.01% | -20.62% | -43.66% | -66.45% | +15.33% | +341.70% | 355M | |
| +1.03% | -3.45% | -12.28% | -17.73% | -24.28% | -21.24% | -28.80% | +6.99% | -35.04% | 319M | |
| -1.67% | -2.13% | -5.17% | -16.40% | -23.77% | -28.52% | -36.85% | -30.65% | +15.39% | 203M | |
| Average | -0.35% | -1.38% | -1.23% | -7.21% | -16.70% | -15.79% | -7.77% | -2.15% | +36.16% | 1.9B | |
| Weighted average by Cap. | -0.42% | -1.43% | -2.09% | -9.03% | -20.65% | -14.15% | +1.18% | -9.03% | +9.23% |
- Stock Market
- Stocks
- 3349 Stock
- Sector COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
